Adding Mitomycin to BCG as adjuvant intravesical therapy for high-risk, non-muscle-invasive -bladder cancer: A randomised phase 3 trial: The BCG MM Study (ANZUP1301)

D Hayne, M Stockler, AJ Martin, S Mccombie, D Zebic, L Krieger, P Anderson, P Bastick, E Beardsley, A Blatt, M Frydenberg, W Green, J Grummet, C Hawks, J Ischia, A Mitterdorfer, M Patel, M Roberts, S Sengupta, R Srivastav Show all